| Univariable analysis | Multivariable analysis adjusting for BMI | ||||
---|---|---|---|---|---|---|
Variable | Subdistribution hazard ratio (SHR) | 95% CI | p | Subdistribution hazard ratio (SHR) | 95% CI | p |
Age at diagnosis (per 5 years increase) | 0.93 | 0.81–1.06 | 0.29 | 0.85 | 0.70–1.02 | 0.09 |
BMI (per 5 kg/m2 increase) | 1.57 | 1.23–2.02 | <0.0001 | N/A | N/A | N/A |
KI at diagnosis | ||||||
 100% | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 < 100% | 0.28 | 0.06–1.35 | 0.11 | 0.31 | 0.07–1.48 | 0.14 |
 Family history of CRC | 1.00 | 0.12–8.23 | 0.99 | 1.19 | 0.14–10.22 | 0.87 |
 Smoker or Ex-Smoker | 1.64 | 0.44–6.09 | 0.46 | 1.71 | 0.43–6.85 | 0.45 |
Tumor localization | ||||||
 Non-rectal | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 Rectal | 0.97 | 0.35–2.68 | 0.95 | 1.74 | 0.5–6.11 | 0.39 |
TNM – T | ||||||
 T1 & T2 & T3 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 T4 | 0.95 | 0.27–3.36 | 0.94 | 0.53 | 0.06–4.80 | 0.57 |
TNM - N | ||||||
 N0 | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 N1 & N2 | 0.85 | 0.29–2.46 | 0.76 | 1.14 | 0.28–4.66 | 0.86 |
Stage | ||||||
 Stage II | Ref. | Ref. | Ref. | Ref. | Ref. | Ref. |
 Stage III | 1.15 | 0.37–3.59 | 0.81 | 1.75 | 0.40–7.63 | 0.46 |
Adjuvant chemotherapy | 0.98 | 0.33–2.88 | 0.97 | 1.18 | 0.27–5.24 | 0.23 |